A case report of papillary cystadenocarcinoma of the prostate
10.3760/cma.j.cn112330-20240625-00288
- VernacularTitle:前列腺乳头状囊腺癌1例报告
- Author:
Bo LIU
1
;
Ningning TIAN
1
;
Shuaibing LIU
1
;
Qingjiao ZHANG
1
;
Chengwen LI
1
Author Information
1. 天津市第四中心医院泌尿外科，天津 300140
- Publication Type:Journal Article
- Keywords:
Prostate cancer;
Papillary cystadenocarcinoma;
Prostate
- From:
Chinese Journal of Urology
2025;46(2):151-152
- CountryChina
- Language:Chinese
-
Abstract:
Papillary cystadenocarcinoma of the prostate is a clinically rare condition, and we admitted one case in September 2022. The patient was an 82-year-old male presenting with asymptomatic gross hematuria for one week. Cystoscopy revealed a papillary lesion located anterior to the verumontanum. During surgery, resection of the urethral lesion and prostate tissue showed that the tumor base originated from the cystically dilated prostate gland with multiple papillary lesions. Postoperative pathological diagnosis confirmed papillary cystadenocarcinoma of the prostate. The patient was followed up for 18 months without recurrence of hematuria or other symptoms. Papillary cystadenocarcinoma of the prostate exhibits distinct aggressive and recurrent characteristics. For patients with a pathologically confirmed diagnosis, given the current unclear effectiveness of radiotherapy and chemotherapy, it is advisable to prioritize radical surgical treatment and/or lymph node dissection in patients with good general condition to achieve a better prognosis.
